Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Publication type

Year

Classification

Organization

Show Sort by

Your filters: cql: author="Al-Akash, Samhar I" or (type exact bookEditor and editor="Al-Akash, Samhar I")

Add to list
- Journal Article
- A1
- open access
Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Larry A Greenbaum, Marc Fila, Gianluigi Ardissino, Samhar I Al-Akash, Jonathan Evans, Paul Henning, Kenneth V Lieberman, Silvio Maringhini, Lars Pape, Lesley Rees, et al.

(2016) KIDNEY INTERNATIONAL. 89(3). p.701-711
Add to list
- Conference Paper
- C3
- open access
Eculizumab (ECU) inhibits thrombotic microangiopathy (TMA) and improves renal function in pediatric patients (Pts) with atypical hemolytic uremic syndrome (aHUS)

Larry A Greenbaum, Marc Fila, Gianluigi Ardissino, Samhar I Al-Akash, Jonathan Evans, Paul Henning, Kenneth V Lieberman, Silvio Maringhini, Lars Pape, Lesley Rees, et al.

(2013) BLOOD. 122(21).
Add to list
- Conference Paper
- C3
- open access
Eculizumab inhibits thrombotic microangiopathy and improves renal function in pediatric patients with atypical hemolytic uremic syndrome

Larry Greenbaum, Marc Fila, Michel Tsimaratos, Gianluigi Ardissimo, Samhar I Al-Akash, Jonathan Evans, Paul Henning, Kenneth V Lieberman, Silvio Maringhini, Lars Pape, et al.

(2013) ASN Kidney Week, Abstracts.